Page last updated: 2024-09-03

gastrodin and alpha-synuclein

gastrodin has been researched along with alpha-synuclein in 1 studies

Compound Research Comparison

Studies (gastrodin)	Trials (gastrodin)	Recent Studies (post-2010) (gastrodin)	Studies (alpha-synuclein)	Trials (alpha-synuclein)	Recent Studies (post-2010) (alpha-synuclein)
302	3	234	10,821	29	8,011

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, X; Li, Z; Yan, J; Yang, Z; Zhao, N	1

Other Studies

1 other study(ies) available for gastrodin and alpha-synuclein

Article	Year
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model. BMC neuroscience, 2019, 06-17, Volume: 20, Issue:1 Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Benzyl Alcohols; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Chemotaxis; Dopaminergic Neurons; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glucosides; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptor, Insulin; Signal Transduction	2019

Article

Year

Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.

BMC neuroscience, 2019, 06-17, Volume: 20, Issue:1

Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Benzyl Alcohols; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Chemotaxis; Dopaminergic Neurons; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glucosides; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptor, Insulin; Signal Transduction

2019